about
An integrated drug development approach applying topological descriptors.High-throughput drug repositioning for the discovery of new treatments for Chagas disease.Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir.Prediction of drug intestinal absorption by new linear and non-linear QSPR.A successful virtual screening application: prediction of anticonvulsant activity in MES test of widely used pharmaceutical and food preservatives methylparaben and propylparaben.The application of molecular topology for ulcerative colitis drug discovery.Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.Identification of levothyroxine antichagasic activity through computer-aided drug repurposingApplication of Computer-Aided Drug Repurposing in the Search of New Cruzipain Inhibitors: Discovery of Amiodarone and Bromocriptine Inhibitory EffectsApplication of descriptors based on Lipinski's rules in the QSPR study of aqueous solubilitiesSynthesis of 2-hydrazolyl-4-thiazolidinones based on multicomponent reactions and biological evaluation against Trypanosoma CruziIn Silico Drug Repositioning for Chagas DiseaseCombined therapy with Benznidazole and repurposed drugs Clofazimine and Benidipine for chronic Chagas diseaseQuantitative structure-activity relationship models for compounds with anticonvulsant activityChallenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
P50
Q38021822-76259D91-F9E6-4188-8112-3D0550C05A3DQ38377145-B22174F6-F31B-4F09-9386-CD55D87A4D78Q40662799-176F6A46-FB3D-4A5B-A86F-7ADC67C8BCEBQ41468933-28FD83B4-B749-459C-9A70-63736B5499E0Q43921052-53EDE602-9F23-4174-97C8-AF65FD42FBE7Q46932252-755C6F63-A4BB-4027-A8BF-8A15C7E85E5CQ52448502-855F0DF6-6058-4109-A994-DA5341AA1DADQ54217459-E9825CFB-C7F0-4140-8C16-4A73590098B9Q59075291-E05FB028-5B0B-4C63-AAA6-A2A129E9CC9CQ62128103-6BAE34FC-04CE-42DE-ADAD-02BB4BEFECC0Q80121181-BC565AB4-9348-42E6-8047-9735B189BBD4Q83249365-D8952AE5-0C7F-4857-A205-7C6155C7721BQ90769534-C7D67ABF-DDDC-4063-B944-8716B239A9CEQ90823480-176D3F03-D2AD-4DF9-9C41-E43FB44948FFQ91892192-52BB6B21-EE48-4CBC-A13F-D2D179581DE1Q92053215-CF0BCDC4-C1C1-45F5-A0EF-0118C88C4617
P50
description
hulumtuese
@sq
investigadora
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carolina L. Bellera
@ast
Carolina L. Bellera
@en
Carolina L. Bellera
@es
Carolina L. Bellera
@nl
type
label
Carolina L. Bellera
@ast
Carolina L. Bellera
@en
Carolina L. Bellera
@es
Carolina L. Bellera
@nl
altLabel
C. L. Bellera
@es
Carolina Bellera
@es
prefLabel
Carolina L. Bellera
@ast
Carolina L. Bellera
@en
Carolina L. Bellera
@es
Carolina L. Bellera
@nl
P106
P1960
igqB7Y4AAAAJ
P21
P31
P496
0000-0002-1237-4929